Tag Archives: Multiomic Health

7 February 2024

News, Press Release

MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen’s University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD).

Multiomic Health Partnership Press Release

24 May 2023

Articles, News from the Team

A paper by the MultiOmic team members was published in the May issue of the ICT magazine

What insight can recent trials give us into how molecular-level disease drivers can be used to enter into a new era of precision nephrology?

Biomarkers CKD Clinical Trials ICT Multiomic Health Nephrology

4 May 2023

News, Press Release

MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions

MultiOmic Health has closed a £5 million seed extension round to build its precision therapeutics discovery platform for metabolic syndrome.

Fundraising Multiomic Health Press Release

6 December 2022

News, Press Release

MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease

Multiomic Health NCA Partnership Press Release

4 October 2022

Leveraging AI to Tackle the Looming Metabolic Syndrome Crisis

In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precision medicine.

AI Drug Discovery Mesh Bio Metabolic Syndrome Multiomic Health

8 July 2022

Understanding the AI-enabled Drug Discovery Landscape

An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health.

AI Drug Discovery Multiomic Health The Pharma Letter

1 July 2022

Interview, Podcast

The Pharma Letter Podcast — Episode 15 — Can AI find new drugs for metabolic diseases?

In this week’s episode of The Pharma Letter Podcast, MultiOmic chief executive Robert Thong discusses his firm’s progress and ambitions for the future.

AI Multiomic Health Podcast Robert Thong The Pharma Letter

30 June 2022

MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines and Diagnostics for Chronic Metabolic Disease

MultiOmic Health and Mesh Bio announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease.

Mesh Bio Multiomic Health Partnership Press Release

8/8

COPYRIGHT notice

All the content on multiomic.health is either self-generated by Multiomic Health Limited, or readily available in various places on the Internet and therefore believed to be in the public domain. Transparent PNG images uploaded are believed to be posted within our rights according to the U.S. Copyright Fair Use Act (Title 17, U.S. Code.) and comparable regulations in other countries.

multiomic.health complies with 17 U.S.C. 512 and the Digital Millennium Copyright Act (“DMCA”). It is our policy to respond to any infringement notices and take appropriate actions under the DMCA and other applicable intellectual property laws.

If by any chance your copyrighted material has been posted on multiomic.health or if links to your copyrighted material are returned through a search engine and you wish this material removed, please provide a written statement identifying in sufficient detail the copyrighted work claimed to have been infringed. You may use the contact form at the end of the landing page for the purposes of such written communication.

DATA SOURCES

https://ourworldindata.org/causes-of-death

https://ourworldindata.org/obesity

https://bmjopen.bmj.com/content/10/8/e036663

How Prevalent is NASH?

https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf?la=en

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/

https://www.cdc.gov/obesity/data/adult.html

https://stop.publichealth.gwu.edu/sites/stop.publichealth.gwu.edu/files/documents/Fast%20Facts%20Cost%20of%20Obesity.pdf

https://www.sciencedirect.com/science/article/abs/pii/S2211883717300187

https://journals.lww.com/jcge/Abstract/2015/09000/The_Epidemiology_of_Cirrhosis_in_the_United.12.aspx#:~:text=The%20prevalence%20of%20cirrhosis%20in%20the%20United%20States%20was%20approximately,unaware%20of%20having%20liver%20disease

How Prevalent is NASH?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743497/#:~:text=In%20the%20United%20States%2C%20NAFLD,nearly%2025%25%20progress%20to%20NASH

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767/

https://www.nature.com/articles/nrgastro.2017.109

https://www.diabetes.org/resources/statistics/statistics-about-diabetes#:~:text=Prevalence%3A%20In%202018%2C%2034.2%20million,of%20the%20population%2C%20had%20diabetes.&text=Undiagnosed%3A%20Of%20the%2034.2%20million,and%207.3%20million%20were%20undiagnos

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.worldobesity.org/news/world-obesity-day-all-countries-significantly-off-track-to-meet-2025-who-targets-on-obesity